Skip to content

The Effect of High-Calorie Formula on Nutritional and Clinical Outcomes Among Infants After Congenital Heart Surgery

The Effect of High-calorie Density Formula Versus Standard Formula in Calorie Intake, Nutritional Status, and Clinical Outcomes Among Infants Who Underwent Congenital Heart Disease Surgery: A Randomized, Double-blind Controlled Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05945459
Enrollment
158
Registered
2023-07-14
Start date
2018-02-14
Completion date
2020-02-15
Last updated
2023-07-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Congenital Heart Disease in Children, Malnutrition, Child

Keywords

anthropometry, congenital heart disease, infant formula, nutritional status, randomized controlled trial

Brief summary

The goal of this clinical trial is to compare the effect of high-calorie density formula (HDF) and standard formula (SF) in infants with congenital heart surgery. The main questions it aims to answer are: 1. Is there any difference in nutritional status between both groups after 3 months? 2. Is there any difference in calorie intake per day between both groups during hospitalization? 3. Is there any difference in clinical outcomes (mortality, duration of using mechanical ventilation, length of stay, and events of side effects) between both groups? A group of participants will be given HDF (1 kcal/ml) from enrollment until three months. Researchers will compare them to the group of participants who are given SF (0.67 kcal/ml) to see if there is any difference in nutritional status, calorie intake, and other clinical outcomes between the two groups.

Detailed description

The study is a randomized, double-blind controlled trial to compare the efficacy of HDF formula compared to SF in nutritional and clinical outcomes among infants who had congenital heart surgery in Harapan Kita National Cardiovascular Centre (HKNCC), Jakarta, Indonesia. The researchers use consecutive sampling to include eligible infants and obtain informed consent from the parent or legal guardian of infants who fulfilled the eligibility criteria. Block randomization is done by a research assistant, and then the allocation is prepared using a sealed envelope to assign infants into HDF and SF groups. Participants are then assessed by a multi-professional team and given enteral feeds based on local guidelines. Routine follow-up is done at 2 weeks, 1 month, 2 months, and 3 months after the intervention to record weight, length, and any episode of complication or adverse events.

Interventions

DIETARY_SUPPLEMENTHigh-calorie density formula (1 kcal/ml)

The dose is started from 20ml/kg/day divided into 8 feeds and increased by 20ml/kg/day until the feeding goal is reached (120-150ml/kg/day) during hospitalization. The intervention is then continued after discharge for 3 months (ad libitum).

DIETARY_SUPPLEMENTStandard formula (0.67 kcal/ml)

The dose is started from 20ml/kg/day divided into 8 feeds and increased by 20ml/kg/day until the feeding goal is reached (120-150ml/kg/day) during hospitalization. The intervention is then continued after discharge for 3 months (ad libitum).

Sponsors

Danone Institute International
CollaboratorOTHER
National Cardiovascular Center Harapan Kita Hospital Indonesia
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
14 Days to 1 Years
Healthy volunteers
No

Inclusion criteria

* Patient of less than 1 year of age who underwent congenital heart surgery procedure in Harapan Kita National Cardiovascular Center * Risk adjustment for congenital heart surgery (RACHS) score 2-4 * Patients who do not get exclusive breastfeeding due to any cause

Exclusion criteria

* History of prematurity (\<37 weeks gestational age) * Formula intolerance or cow milk protein allergy * Lethal chromosome abnormality * Galactosemia * Gastrointestinal malformation or obstruction * Renal failure * Liver disease * Metabolic abnormalities * Need for extracorporeal membrane oxygenation Drop-out * Patients who develop diarrhea for more than 5 days during the study period despite getting adequate therapy * Patients who need prolonged total parenteral nutrition (e.g., gastrointestinal bleeding due to any cause, chylothorax, etc.) * Patients with necrotizing enterocolitis during the study period

Design outcomes

Primary

MeasureTime frameDescription
Nutritional statusAfter 3 months of interventionNumeric data of weight-for-length z-score (WLZ), length-for-age z-score (LAZ) and weight-for-age z-score (WAZ) based on the 2006 World Health Organization (WHO) Child Growth Standard

Secondary

MeasureTime frameDescription
Calorie intakeFrom the date of randomization to the date of discharge, assessed up to 3 monthsNumeric data of the infants' total calorie intake (kcal/kg/day) during hospitalization
WeightAfter 1, 2, and 3 months of interventionNumeric data of absolute weight (kg)
LengthAfter 1, 2, and 3 months of interventionNumeric data of absolute length (cm)
Weight-for-age z-score changesFrom the date of randomization to after 1, 2, and 3 months of interventionDifference of weight-for-age z-score based on The 2006 WHO Child Growth Standard
Length-for-age z-score changesFrom the date of randomization to after 1, 2, and 3 months of interventionDifference of length-for-age z-score based on The 2006 WHO Child Growth Standard
Weight-for-length z-score changesFrom the date of randomization to after 1, 2, and 3 months of interventionDifference of weight-for-length z-score based on The 2006 WHO Child Growth Standard
Malnutrition riskAfter 1, 2, and 3 months of interventionRisk ratios of malnutrition, defined as weight-for-length \<-2 based on 2006 WHO Child Growth Standard
MortalityThrough study completion, an average of 3 monthsThe event proportion of mortality (%)
Duration of mechanical ventilationFrom the date of randomization to the date of hospital discharge, assessed up to 3 monthsThe difference of mechanical ventilation duration (hours)
Length of stayFrom the date of randomization to the date of discharge, assessed up to 3 monthsThe difference of lengths of stay in intensive care unit and hospital (days)
Side effectsFrom the date of randomization to the date of hospital discharge, assessed up to 3 monthsThe event proportion (%) of vomiting, diarrhea, gastrointestinal bleeding, constipation, and \>50% residual gastric content

Countries

Indonesia

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026